Association of cisplatin and intra-arterial injection of 131I-lipiodol in treatment of hepatocellular carcinoma: Results of phase II trial

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 3, 2006, Pages 745-750

  Raoul, Jean Luc ^a   Boucher, Eveline ^a   Olivie, Damien ^b   Guillygomarc'H, Anne ^b   Boudjema, Karim ^b   Garin, Etienne ^a  

^a CENTRE EUGÈNE MARQUIS   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

131I lipiodol; Chemotherapy; Combined treatment; Hepatocellular carcinoma; Internal radiotherapy

Indexed keywords

CELL CULTURE; CHEMOTHERAPY; CYTOLOGY; RADIOTHERAPY; TOXICITY; TUMORS;

131-I LIPIDOL; COMBINED TREATMENT; HEPATOCELLULAR CARCINOMA; INTERNAL RADIOTHERAPY;

PATIENT TREATMENT;

CISPLATIN; IODINATED POPPYSEED OIL; IODINATED POPPYSEED OIL I 131; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASCITES; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFECTION; LIVER CELL CARCINOMA; LUNG TOXICITY; MALE; NAUSEA; NEUTROPENIA; NONHUMAN; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 31844435837     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.09.007     Document Type: Article

References (27)

1. J.M. Llovet, M.I. Real, X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma A randomised controlled study Lancet 359 2002 1734 1739
2. C.M. Lo, H. Ngan, W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
3. 90yttrium microspheres Int J Radiat Oncol Biol Phys 40 1998 583 592
4. 131I-labeled- iodized oil in the treatment of hepatocellular carcinoma Hepatology 26 1997 1156 1161
5. N. Chenoufi, J.L. Raoul, G. Lescoat In vitro demonstration of synergy between radionuclide and chemotherapy J Nucl Med 39 1998 900 903
6. R. Simon Optimal two-stage designs for phase II clinical trials Control Clin Trials 10 1988 1 10
7. J.L. Raoul, J.F. Bretagne, P. Caucanas Internal radiation therapy for hepatocellular carcinoma Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled-lipiodol Cancer 69 1992 346 352
8. J.L. Raoul, D. Guyader, J.F. Bretagne Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis Intra-arterial iodine-131-iodized oil versus medical support J Nucl Med 35 1994 1782 1787
9. H.C. Park, J. Seong, K.H. Han Dose-response relationship in local radiotherapy for hepatocellular carcinoma Int J Radiat Oncol Biol Phys 54 2002 150 155
10. R.A. Abrams, R.M. Cardinale, C. Enger Influence of prognostic grouping and treatment results in the management of unresectable hepatoma Experience with cisplatinum-based chemoradiotherapy in 76 patients Int J Radiat Oncol Biol Phys 39 1997 1077 1085
11. S. Okada, N. Okazaki, H. Nose A phase 2 study of cisplatin in patients with hepatocellular carcinoma Oncology 50 1993 22 26
12. J. Taieb, E. Mitry, V. Boige Optimization of 5-fluorouracil/cisplatin combination chemotherapy with a new schedule of leucovorin, 5 FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma Ann Oncol 13 2002 1192 1196
13. 131I labelled lipiodol. I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases Radiology 168 1988 541 545
14. W.S. Court, S.E. Order, J.A. Siegel Remission and survival following monthly intra arterial cisplatinum in nonresectable hepatoma Cancer Invest 20 2002 613 625
15. 131I- labeled lipiodol Br J Surg 90 2003 1379 1383
16. E. Boucher, S. Corbinais, P. Brissot Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen) Cancer Chemother Pharmacol 50 2002 305 308
17. J.W. Chung, J.H. Park, J.G. Im Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma Radiology 187 1993 689 693
18. T. Tajima, H. Honda, T. Kuroiwa Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer J Vasc Interv Radiol 13 2002 893 900
19. P.C. Kwok, T.W. Lam, C.L. Lam Rare pulmonary complications after transarterial chemoembolization for hepatocellular carcinoma Two case reports Hong Kong Med J 9 2003 457 460
20. 131I-lipiodol therapy for hepatocellular carcinoma Nucl Med Com 24 2003 671 678
21. 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer Preclinical study in a rabbit liver cancer model J Nucl Med 44 2003 2033 2038
22. B. Lambert, L. De Ridder, G. Slegers Screening for supra-additive effects of cytotoxic drugs and gamma irradiation in an in vitro model for hepatocellular carcinoma Can J Physiol Pharmacol 82 2004 146 152
23. B. Brans, K. Van Laere, F. Gemmel Combining iodine-131 lipiodol therapy with low-dose cisplatin as a radiosensitiser Preliminary results in hepatocellular carcinoma Eur J Nucl Med Mol Imaging 29 2002 928 932
24. 188Re-SSS lipiodol Radiolabeling and biodistribution following injection into the hepatic artery of rats bearing hepatoma Nucl Med Commun 25 2004 1007 1013
25. F. Sundram, T.C. Chau, P. Onkhuudai Preliminary results of transarterial rhenium-188 lipiodol in the treatment of inoperable primary hepatocellular carcinoma Eur J Nucl Med Mol Imaging 31 2004 250 257
26. 188Re-lipiodol Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma Nucl Med Commun 25 2004 691 699
27. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma A phase I clinical trial J Nucl Med 46 2005 60 66